Vaxxas bio-tech firm to launch clinical trials of 'needle-free vaccine patches' for COVID
Vaxxas' head of medical device and process engineering, Michael Junger stated the firm has planned to start human trials in the middle of 2022
Michael Junger University Of Queensland Sciences Advances Journal Vaxxa Head Medical Device Process Engineering
Source: republicworld.com